The reduced expression of tumor suppressor ING4 has been reported in various malignancies, and down-regulation of ING4 is correlated with increased tumor metastasis, advanced TMN stages and poor patients survival in melanoma [18], gastric cancer [19] and breast cancer [20]. The gene discussed is ING4; the disease is breast carcinoma.